DBV Technologies S.A. (EPA:DBV)
France · Delayed Price · Currency is EUR 1.759
+0.015 (0.86%)
Oct 22, 2026, 5:35 PM CEST
DBV Technologies Market Cap
DBV Technologies has a market cap or net worth of €520.51 million as of October 22, 2026. It is the 13,341st most valuable company in the world and the 181st biggest in France. Its market cap has increased by 37.40% in one year.
Market Cap
520.51M
Enterprise Value
374.16M
Revenue
4.41M
Global Rank
Country Rank
#181 France
PE Ratio
n/a
ChartMarket Cap Chart
Since March 29, 2012, DBV Technologies's market cap has increased from 79.23M to 520.51M, an increase of 556.98%. That is a compound annual growth rate of 13.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 520.51M | -23.24% |
| Dec 31, 2025 | 678.09M | 949.56% |
| Dec 31, 2024 | 64.61M | -63.70% |
| Dec 29, 2023 | 177.98M | -39.80% |
| Dec 30, 2022 | 295.62M | 75.76% |
| Dec 31, 2021 | 168.19M | -29.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.31B |
| MedinCell | 958.84M |
| Inventiva | 744.28M |
| Genfit | 463.29M |
| Valneva SE | 458.76M |
| Valerio Therapeutics Société anonyme | 199.78M |
| Transgene | 185.69M |
| Innate Pharma | 124.62M |